CA1105007A - Traduction non-disponible - Google Patents

Traduction non-disponible

Info

Publication number
CA1105007A
CA1105007A CA286,056A CA286056A CA1105007A CA 1105007 A CA1105007 A CA 1105007A CA 286056 A CA286056 A CA 286056A CA 1105007 A CA1105007 A CA 1105007A
Authority
CA
Canada
Prior art keywords
hydrogen
compound
formula
alkyl
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA286,056A
Other languages
English (en)
Inventor
Peter Stutz
Paul Stadler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1128676A external-priority patent/CH623591A5/de
Priority claimed from CH1128776A external-priority patent/CH623592A5/de
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of CA1105007A publication Critical patent/CA1105007A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CA286,056A 1976-09-06 1977-09-02 Traduction non-disponible Expired CA1105007A (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1128676A CH623591A5 (en) 1976-09-06 1976-09-06 Process for the preparation of ergopeptide alkaloid derivatives
CH11287/76 1976-09-06
CH1128776A CH623592A5 (en) 1976-09-06 1976-09-06 Process for the preparation of ergopeptide alkaloid derivatives
CH11286/76 1976-09-06

Publications (1)

Publication Number Publication Date
CA1105007A true CA1105007A (fr) 1981-07-14

Family

ID=25708069

Family Applications (1)

Application Number Title Priority Date Filing Date
CA286,056A Expired CA1105007A (fr) 1976-09-06 1977-09-02 Traduction non-disponible

Country Status (15)

Country Link
JP (1) JPS5331698A (fr)
AU (1) AU512027B2 (fr)
CA (1) CA1105007A (fr)
DE (1) DE2738730A1 (fr)
DK (1) DK147390C (fr)
ES (1) ES462080A1 (fr)
FI (1) FI64942C (fr)
FR (1) FR2363571A1 (fr)
GB (2) GB1590150A (fr)
IE (1) IE46152B1 (fr)
IL (1) IL52896A (fr)
NL (1) NL7709683A (fr)
NZ (1) NZ185098A (fr)
PT (1) PT67003B (fr)
SE (1) SE435839B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8604035B2 (en) * 2011-06-23 2013-12-10 Map Pharmaceuticals, Inc. Fluoroergoline analogs

Also Published As

Publication number Publication date
IL52896A0 (en) 1977-11-30
DK147390C (da) 1985-02-04
FR2363571A1 (fr) 1978-03-31
JPS5331698A (en) 1978-03-25
GB1590149A (en) 1981-05-28
GB1590150A (en) 1981-05-28
NL7709683A (nl) 1978-03-08
PT67003B (en) 1979-05-14
AU2857277A (en) 1979-03-15
IE46152L (en) 1978-03-06
DK147390B (da) 1984-07-16
FI772557A (fi) 1978-03-07
SE7709645L (sv) 1978-03-07
AU512027B2 (en) 1980-09-18
ES462080A1 (es) 1978-12-01
DK382777A (da) 1978-03-07
IL52896A (en) 1980-07-31
IE46152B1 (en) 1983-03-09
FI64942C (fi) 1984-02-10
FI64942B (fi) 1983-10-31
DE2738730A1 (de) 1978-03-16
PT67003A (en) 1977-10-01
NZ185098A (en) 1980-04-28
FR2363571B1 (fr) 1980-04-18
SE435839B (sv) 1984-10-22

Similar Documents

Publication Publication Date Title
CA1176634A (fr) Triazoloquinoxalin-4-ones
PL108034B1 (pl) Sposob wytwarzania nowych pochodnych tiazolo/3,4-bmethod of producing new derivatives of thiazolo/3,4-b/isoquinoline /izochinoliny
CA1105007A (fr) Traduction non-disponible
GB2152507A (en) 8a-acylaminoergolines
NO161738B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolinderivater.
EP0219256B1 (fr) N-Alkylation de l'acide dihydrolysergique
US4124712A (en) Ergot peptide alkaloid derivatives
PL72567B1 (fr)
SU930902A1 (ru) Производные тиено [3,2=в] индола
US4229451A (en) Ergopeptine derivatives
CA1099261A (fr) Composes d'ergolene et d'ergoline et methode de preparation
JP2000516240A (ja) Ｎ―［（１―▲上ｎ▼ブチル―４―ピペリジル）メチル］―３，４―ジヒドロ―２Ｈ―［１，３］オキサジノ［３，２―ａ］インドール―１０―カルボキシアミドおよび塩ならびに製造における中間体
US3666762A (en) 2{40 {62 -ISOPROPYL-5{40 {60 -n-PROPYL-9,10-DIHYDRO-ERGOPEPTINES
NO317997B1 (no) Fremgangsmate for fremstilling av et naftyridinkarboksylsyrederivat (metansulfonat-sesquihydrat)
US4088647A (en) Pyrazino (1,2,3-ab)-β-carboline derivatives and salts thereof and method of preparing same
CA1044237A (fr) Derives de la triazolo-isoquinoline
US3901891A (en) 13-bromolysergic acid compounds
IE910244A1 (en) Process for preparing ergoline derivatives
CA2137611A1 (fr) Derives de l'epi-epibatidine
US4248871A (en) N-9,10-Dihydrolysergyl-m-aminobenzoic acid amide derivative
Duncan Jr et al. Synthesis of Indolo and benzimidazoquinazolines and benzodiazepines
US4000139A (en) Organic compounds
US3227719A (en) Pyrazines
US3314959A (en) Intermediates for the synthesis of ergot alkaloids
US3422110A (en) Ergot alkaloids methylated in the 10a'-position

Legal Events

Date Code Title Description
MKEX Expiry